Novozymes A/S
NSIS-B
Clasificación en acciones
#821
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global... Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.
Precio por acción
$71.08
Capitalización bursátil
$29.32B
Cambio (1 día)
1.13%
Cambio (1 año)
11.94%
País
DK
Comercio Novozymes A/S (NSIS-B)
Categoría
Basic Materials
Ratio P/E de Novozymes A/S (NSIS-B)
Ratio P/E al 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Novozymes A/S, el P/E actual (TTM) de la empresa es 0. Al final de 2026, la empresa tenía un P/E de 0.
Historial del ratio P/E de Novozymes A/S desde 2013 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2025 | 326.24 | -11.95% |
| 2024 | 370.50 | 998.99% |
| 2023 | 33.71 | 26.36% |
| 2022 | 26.68 | -43.78% |
| 2021 | 47.46 | 36.79% |
| 2020 | 34.69 | 17.17% |
| 2019 | 29.61 | 13.36% |
| 2018 | 26.12 | -22.71% |
| 2017 | 33.79 | 39.62% |
| 2016 | 24.20 | -33.23% |
| 2015 | 36.25 | 11.90% |
| 2014 | 32.39 | -1.93% |
| 2013 | 33.03 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 31.66 | - |
GB
|
|
| 29.55 | - |
FR
|
|
| 29.64 | - |
US
|
|
| 38.39 | - |
US
|
|
| -1.46K | - |
US
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.